These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6228391)

  • 1. In vitro activity of norfloxacin against Neisseria gonorrhoeae.
    Piffaretti JC; Arini A; Peduzzi R
    Chemotherapy; 1983; 29(6):415-8. PubMed ID: 6228391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activity of norfloxacin against resistant Neisseria gonorrhoeae.
    Ponticas S; Shungu DL; Gill CJ
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):626-8. PubMed ID: 2528454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
    Sweet RL; Ohm-Smith MJ; Hadley WK
    J Antimicrob Chemother; 1982 Dec; 10(6):553-7. PubMed ID: 6219085
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jul; 22(1):23-7. PubMed ID: 6214995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
    Khan MY; Siddiqui Y; Gruninger RP
    Antimicrob Agents Chemother; 1981 Aug; 20(2):265-6. PubMed ID: 6456692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of different auxotypes of Neisseria gonorrhoeae to norfloxacin, cefotaxime, cefuroxime, and erythromycin.
    Noble RC; Parekh MC
    Sex Transm Dis; 1984; 11(3):152-5. PubMed ID: 6095474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin.
    Crider SR; Colby SD; Miller LK; Harrison WO; Kerbs SB; Berg SW
    N Engl J Med; 1984 Jul; 311(3):137-40. PubMed ID: 6234465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of norfloxacin (MK-0366).
    King A; Warren C; Shannon K; Phillips I
    Antimicrob Agents Chemother; 1982 Apr; 21(4):604-7. PubMed ID: 6211139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.
    Shungu DL; Tutlane VK; Weinberg E; Gadebusch HH
    Chemotherapy; 1985; 31(2):112-8. PubMed ID: 3157551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of in vitro antimicrobial activity of AM-1155 with those of tosufloxacin and fleroxacin against clinical isolates of Neisseria gonorrhoeae harboring quinolone resistance alterations in GyrA and ParC.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Fukuda H; Maeda S; Saito I; Kawada Y
    Chemotherapy; 1997; 43(4):239-44. PubMed ID: 9209780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
    Peeters M; Van Dyck E; Piot P
    Antimicrob Agents Chemother; 1984 Oct; 26(4):608-9. PubMed ID: 6240224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
    Corrado ML; Cherubin CE; Shulman M
    J Antimicrob Chemother; 1983 Apr; 11(4):369-76. PubMed ID: 6222023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents.
    Neu HC; Chin NX; Labthavikul P; Saha G
    Chemioterapia; 1984 Aug; 3(4):235-41. PubMed ID: 6241847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents.
    Gadebusch HH; Shungu DL; Weinberg E; Chung SK
    Infection; 1982 Jan; 10(1):41-4. PubMed ID: 6461606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.
    Wise R; Andrews JM; Edwards LJ
    Antimicrob Agents Chemother; 1983 Apr; 23(4):559-64. PubMed ID: 6222695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of thiamphenicol against Chlamydia trachomatis and Neisseria gonorrhoeae.
    Ridgway GL; Felmingham D; Mumtaz G; O'Hare M
    Sex Transm Dis; 1984; 11(4 Suppl):432-4. PubMed ID: 6441286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced uptake and accumulation of norfloxacin in resistant strains of Neisseria gonorrhoeae isolated in Japan.
    Tanaka M; Fukuda H; Hirai K; Hosaka M; Matsumoto T; Kumazawa J
    Genitourin Med; 1994 Aug; 70(4):253-5. PubMed ID: 7959709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity.
    Goldstein EJ
    Am J Med; 1987 Jun; 82(6B):3-17. PubMed ID: 3111257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.